H.C. Wainwright Starts Generate Biomedicines (GENB) at Buy
Tweet
Share
E-mailGet Alerts GENB Hot Sheet
Price: $17.41 +5.52%
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE
H.C. Wainwright initiates coverage on Generate Biomedicines (NASDAQ: GENB) with a Buy rating and a price target of $16.00.
For an analyst ratings summary and ratings history on Generate Biomedicines click here. For more ratings news on Generate Biomedicines click here.
Shares of Generate Biomedicines closed at $11.41 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Correction: Kepler Cheuvreux Upgrades Siemens AG (SIE:GR) (SIEGY) to Hold
- JPMorgan Starts Kanzhun Ltd (2076:HK) at Overweight
- Morgan Stanley Upgrades Galp Energia SGPS SA (GALP:LI) (GLPEF) to Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Maynard Um, H.C. Wainwright, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
